The device promises to revolutionise the speed, accuracy and reliability with which patients presenting with symptoms of deep vein thrombosis (DVT) can assessed at the point of first contact. The handheld device will be mobile, enabling clinicians to use the device any time, anywhere.  The accuracy and reliability of its results will help reduce related healthcare costs.